RCEL · AVITA Medical Inc
United States · RS rating 99 · As of 2026-11-03
| Price | 15.33 USD |
|---|---|
| 1-day change | -0.5% |
| RS rating (overall / 1M / 3M / 12M) | 99 / 90 / 98 / 98 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 44 / 76 / 50 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +17.4% |
| Sales growth Q/Q | +3.2% |
| Distance from 52-week high | +8.3% |
| Market cap (USD) | $133.3M |